Apyx Medical (NASDAQ:APYX) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Apyx Medical (NASDAQ:APYX) issued its earnings results on Thursday. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.02, Zacks reports. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Stock Performance

NASDAQ:APYX traded up $0.02 during midday trading on Thursday, reaching $1.09. 11,116 shares of the company traded hands, compared to its average volume of 66,209. The firm has a market capitalization of $41.03 million, a price-to-earnings ratio of -1.31 and a beta of 1.18. The company has a fifty day moving average price of $1.43 and a 200 day moving average price of $1.38. The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. Apyx Medical has a twelve month low of $0.97 and a twelve month high of $1.99.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.